NIOX Group (LON:NIOX) Stock Price Down 1.5% - Here's What Happened

NIOX Group Plc (LON:NIOX - Get Free Report) was down 1.5% on Thursday . The stock traded as low as GBX 63.60 ($0.86) and last traded at GBX 64 ($0.87). Approximately 179,760 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 1,235,947 shares. The stock had previously closed at GBX 65 ($0.88).

Wall Street Analysts Forecast Growth

NIOX has been the subject of several recent research reports. Berenberg Bank reiterated a "buy" rating and set a GBX 90 ($1.22) price target on shares of NIOX Group in a research report on Tuesday, April 15th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 90 ($1.22) target price on shares of NIOX Group in a research report on Tuesday, April 15th.

NIOX Group Price Performance

The company has a debt-to-equity ratio of 1.10, a current ratio of 6.31 and a quick ratio of 1.94. The company has a market cap of £26.29 billion, a PE ratio of 2,641.17 and a beta of 0.92. The stock has a fifty day moving average price of GBX 65.20 and a 200-day moving average price of GBX 64.30.

NIOX Group (LON:NIOX - Get Free Report) last released its earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) EPS for the quarter. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%. On average, equities analysts expect that NIOX Group Plc will post 1.1658256 earnings per share for the current year.

Insiders Place Their Bets

In other NIOX Group news, insider Ian Johnson sold 3,924,630 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of GBX 65 ($0.88), for a total transaction of £2,551,009.50 ($3,453,844.44). Also, insider Jonathan Emms purchased 127,454 shares of the firm's stock in a transaction on Tuesday, April 1st. The shares were purchased at an average cost of GBX 8 ($0.11) per share, with a total value of £10,196.32 ($13,804.93). Insiders own 46.72% of the company's stock.

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.